REFERENCES
- Dunbar L, Brandt T, Wheeler A, Harrison J, Condell W, Stoepker J. Implementing metabolic risk assessment in a secondary care mental health service. Australasian Psychiatry 2010; 18: 318–321.
- Barnes TRE, Paton C, Cavanagh MR, Hancock E, Taylor DM. A UK audit of screening for the metabolic side effects of antipsychotics in community patients. Schizophrenia Bulletin 2007; 33: 1397–1403.
- Hyland B, Judd F, Davidson S, Jolley D, Hocking B. Case managers’ attitudes to the physical health of their patients. Australian and New Zealand Journal of Psychiatry 2003; 37: 710–714.
- Druss BG, Marcus SC, Campbell J . Medical services for clients in community mental health centers: results from a national survey. Psychiatric Services 2008; 59: 917–920.
- Wheeler A, Harrison J, Homes Z. Cardiovascular risk assessment and management in mental health clients: perceptions of mental health and general practitioners in New Zealand. Journal of Primary Health Care 2009; 1: 11–19.
- Boardman JB. Health access and integration for adults with serious and persistent mental illness. Families, Systems & Health: The Journal of Collaborative Family HealthCare 2006; 24: 3–18.
- Mackin P, Bishop DR, Watkinson HMO. A prospective study of monitoring practices for metabolic disease in antipsychotic-treated community psychiatric patients. BMC Psychiatry 2007; 7: 28.
- Taylor D, Young C, Esop R, Paton C, Walwyn R. Testing for diabetes in hospitalised patients prescribed antipsychotic drugs. British Journal of Psychiatry 2004; 185: 152–156.
- Runcie O, Boilson M, Hamilton R. Monitoring weight and blood glucose in in-patients: how helpful is a protocol? Psychiatric Bulletin 2007; 31: 88–91.
- Barnes TRE, Paton C, Hancock E, Cavanagh MR, Taylor D, Lelliott P. Screening for the metabolic syndrome in community psychiatric patients prescribed antipsychotics: A quality improvement programme. Acta Psychiatrica Scandinavica 2008; 118: 26–33.
- Newcomer JW, Nasrallah HA, McIntyre RS, Hennekens CH, Vogel-Scibilia S. Elevating the standard of care in the management of cardiometabolic risk factors in patients with mental illness. CNS Spectrums 2008; 13: 1–14.
- Walter G, DeLaroche A, Soh N . Side effects of second generation antipsychotics: the experience, views and monitoring practices of Australian child psychiatrists. Australasian Psychiatry 2008; 16: 253–262.
- Nguyen D, Brakoulias V, Boyce P. An evaluation of monitoring practices in patients on second generation antipsychotics. Australasian Psychiatry 2009; 17: 295–299.